Your browser is no longer supported. Please, upgrade your browser.
Settings
ZOM Zomedica Pharmaceuticals Corp. daily Stock Chart
ZOM [AMEX]
Zomedica Pharmaceuticals Corp.
Index- P/E- EPS (ttm)-0.10 Insider Own38.45% Shs Outstand361.04M Perf Week-27.59%
Market Cap70.40M Forward P/E- EPS next Y-0.03 Insider Trans0.00% Shs Float141.92M Perf Month-4.55%
Income-10.60M PEG- EPS next Q-0.01 Inst Own5.00% Short Float5.04% Perf Quarter1.88%
Sales- P/S- EPS this Y-4.50% Inst Trans249.94% Short Ratio0.14 Perf Half Y-49.18%
Book/sh-0.08 P/B- EPS next Y25.00% ROA-166.90% Target Price- Perf Year-33.86%
Cash/sh0.00 P/C46.93 EPS next 5Y- ROE135.90% 52W Range0.11 - 0.50 Perf YTD-49.24%
Dividend- P/FCF- EPS past 5Y-28.50% ROI- 52W High-66.33% Beta0.10
Dividend %- Quick Ratio1.20 Sales past 5Y- Gross Margin- 52W Low52.73% ATR0.03
Employees28 Current Ratio1.20 Sales Q/Q- Oper. Margin- RSI (14)42.64 Volatility15.81% 13.27%
OptionableNo Debt/Eq- EPS Q/Q82.10% Profit Margin- Rel Volume5.68 Prev Close0.22
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume50.27M Price0.17
Recom2.00 SMA20-18.94% SMA50-17.00% SMA200-35.22% Volume285,373,198 Change-25.20%
Jul-01-20 10:30PM  
04:04PM  
Jun-30-20 09:00AM  
Jun-25-20 09:26AM  
Jun-16-20 06:05PM  
May-29-20 04:05PM  
May-26-20 10:16PM  
May-20-20 04:05PM  
May-11-20 06:55PM  
04:20PM  
Apr-21-20 06:55AM  
Apr-13-20 07:15PM  
Apr-07-20 11:32PM  
04:01PM  
Feb-26-20 05:25PM  
Feb-14-20 04:15PM  
Feb-12-20 08:43AM  
Feb-11-20 06:55AM  
Jan-30-20 06:55AM  
Jan-23-20 06:55AM  
Jan-20-20 06:55AM  
Dec-23-19 04:00PM  
Dec-03-19 06:55AM  
Nov-13-19 06:55AM  
Nov-12-19 04:53PM  
Nov-05-19 04:15PM  
Oct-31-19 06:55AM  
Oct-03-19 11:27AM  
Oct-01-19 09:17AM  
Sep-18-19 01:39PM  
Sep-17-19 06:55AM  
Sep-11-19 09:09AM  
09:00AM  
Sep-03-19 06:55AM  
Aug-19-19 06:55AM  
Aug-13-19 08:00AM  
Aug-08-19 04:08PM  
Aug-07-19 06:55AM  
Jul-25-19 06:55AM  
Jul-17-19 06:55AM  
Jun-26-19 10:05AM  
Jun-13-19 06:55AM  
Jun-12-19 04:35PM  
Jun-10-19 06:00AM  
May-21-19 06:55AM  
May-10-19 05:21PM  
06:00AM  
Mar-26-19 06:00AM  
Mar-25-19 04:01PM  
Mar-05-19 06:55AM  
Feb-26-19 04:05PM  
Jan-15-19 06:55AM  
Jan-14-19 06:55AM  
Dec-20-18 05:23PM  
Dec-19-18 06:00AM  
Nov-28-18 09:53AM  
Nov-27-18 06:51AM  
06:50AM  
Nov-26-18 07:25AM  
Nov-13-18 04:47PM  
Nov-12-18 04:30PM  
Oct-16-18 09:00AM  
Sep-18-18 06:55AM  
Aug-15-18 04:15PM  
Aug-09-18 04:01PM  
Jun-28-18 08:57PM  
Jun-25-18 05:59PM  
Jun-19-18 06:54AM  
Jun-14-18 06:15PM  
May-15-18 04:06PM  
04:01PM  
May-14-18 07:30AM  
May-10-18 06:55AM  
May-07-18 06:55AM  
Mar-26-18 09:00AM  
Mar-07-18 06:55AM  
Feb-28-18 04:11PM  
Feb-20-18 06:55AM  
Dec-01-17 09:00AM  
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan.